We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMND icon
1776
Lemonade
LMND
$4.1B
$433K ﹤0.01%
26,860
ARLO icon
1777
Arlo Technologies
ARLO
$1.5B
$433K ﹤0.01%
45,476
AHRT
1778
AH Realty Trust
AHRT
$501M
$432K ﹤0.01%
34,959
CFFN icon
1779
Capitol Federal Financial
CFFN
$1.1B
$432K ﹤0.01%
67,006
BJRI icon
1780
BJ's Restaurants
BJRI
$1.48B
$432K ﹤0.01%
11,997
RGR icon
1781
Sturm, Ruger & Co
RGR
$600M
$432K ﹤0.01%
9,505
SMP icon
1782
Standard Motor Products
SMP
$877M
$431K ﹤0.01%
10,831
ASIX icon
1783
AdvanSix
ASIX
$427M
$431K ﹤0.01%
14,370
POWL icon
1784
Powell Industries
POWL
$7.43B
$430K ﹤0.01%
14,577
TMP icon
1785
Tompkins Financial
TMP
$1.44B
$429K ﹤0.01%
7,125
BFC icon
1786
Bank First Corp
BFC
$1.74B
$429K ﹤0.01%
4,948
FDMT icon
1787
4D Molecular Therapeutics
FDMT
$621M
$427K ﹤0.01%
21,100
MEI icon
1788
Methode Electronics
MEI
$602M
$427K ﹤0.01%
18,798
SPNT icon
1789
SiriusPoint
SPNT
$2.66B
$426K ﹤0.01%
36,689
-11,594
-24% -$122K
CRK icon
1790
Comstock Resources
CRK
$4.09B
$426K ﹤0.01%
48,087
U icon
1791
Unity
U
$20.2B
$425K ﹤0.01%
10,388
-26
-0.2% -$801
ANIP icon
1792
ANI Pharmaceuticals
ANIP
$1.72B
$423K ﹤0.01%
7,676
GRC icon
1793
Gorman-Rupp
GRC
$2.15B
$423K ﹤0.01%
11,912
SPCE icon
1794
Virgin Galactic
SPCE
$475M
$422K ﹤0.01%
8,608
+1,948
+29% +$76.9K
MD icon
1795
Pediatrix Medical
MD
$2.15B
$420K ﹤0.01%
45,151
ASPN icon
1796
Aspen Aerogels
ASPN
$510M
$418K ﹤0.01%
26,511
COCO icon
1797
Vita Coco
COCO
$3.85B
$418K ﹤0.01%
16,295
AMRX icon
1798
Amneal Pharmaceuticals
AMRX
$6.15B
$418K ﹤0.01%
68,810
UTL icon
1799
Unitil
UTL
$984M
$417K ﹤0.01%
7,939
DDD icon
1800
3D Systems Corp
DDD
$603M
$417K ﹤0.01%
65,646

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.